The findings presented in the current study also demonstrate a dose-dependent reduction in Ki67, Nop10, and H2AX expressions in tumor cells around blood vessels, alongside GFAP expression, following treatment with BA in astrocytes surrounding the tumors in rat GBM model. The gene discussed is GFAP; the disease is glioblastoma.